Reducing the number of CTs performed to monitor personalized dosimetry during peptide receptor radionuclide therapy (PRRT)

BACKGROUND: Peptide receptor radionuclide therapy (PRRT) with [(177)Lu]-DOTA-TATE is an effective treatment of neuroendocrine tumors (NETs). After each cycle of treatment, patient dosimetry evaluates the radiation dose to the risk organs, kidneys, and bone marrow, the most radiosensitive tissues. Ab...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:EJNMMI Phys
Hlavní autoři: Chicheportiche, Alexandre, Artoul, Faozi, Schwartz, Arnon, Grozinsky-Glasberg, Simona, Meirovitz, Amichay, Gross, David J., Godefroy, Jeremy
Médium: Artigo
Jazyk:Inglês
Vydáno: Springer International Publishing 2018
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6006002/
https://ncbi.nlm.nih.gov/pubmed/29916115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40658-018-0211-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky